Insider Trading Alert - BWLD, MSON And FCF Traded By Insiders - TheStreet

Yesterday, Sept. 8, 2015, 65 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $218.00 to $671,295.90.

Highlighted Stocks Traded by Insiders:

Buffalo Wild Wings (BWLD) - FREE Research Report

Schmidt James M, who is Chief Operating Officer at Buffalo Wild Wings, sold 1,000 shares at $199.70 on Sept. 8, 2015. Following this transaction, the Chief Operating Officer owned 32,996 shares meaning that the stake was reduced by 2.94% with the 1,000-share transaction.

The shares most recently traded at $202.04, up $2.34, or 1.16% since the insider transaction. Historical insider transactions for Buffalo Wild Wings go as follows:

  • 4-Week # shares bought: 315
  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 315
  • 12-Week # shares sold: 18,477
  • 24-Week # shares bought: 315
  • 24-Week # shares sold: 26,202

The average volume for Buffalo Wild Wings has been 474,800 shares per day over the past 30 days. Buffalo Wild Wings has a market cap of $3.7 billion and is part of the services sector and leisure industry. Shares are up 11.82% year-to-date as of the close of trading on Tuesday.

Buffalo Wild Wings, Inc. owns, operates, and franchises restaurants. The company's restaurants provide various food products, and nonalcoholic and alcoholic beverages. The company has a P/E ratio of 40.5. Currently, there are 13 analysts who rate Buffalo Wild Wings a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BWLD - FREE

TheStreet Quant Ratings

rates Buffalo Wild Wings as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

Buffalo Wild Wings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Misonix (MSON) - FREE Research Report

Zaremba Richard A, who is Senior Vice President and CFO at Misonix, sold 2,031 shares at $11.10 on Sept. 8, 2015. Following this transaction, the Senior Vice President and CFO owned 116,740 shares meaning that the stake was reduced by 1.71% with the 2,031-share transaction.

The shares most recently traded at $10.94, down $0.16, or 1.42% since the insider transaction. Historical insider transactions for Misonix go as follows:

  • 4-Week # shares bought: 100
  • 4-Week # shares sold: 1,555
  • 12-Week # shares bought: 100
  • 12-Week # shares sold: 1,555
  • 24-Week # shares bought: 100
  • 24-Week # shares sold: 5,055

The average volume for Misonix has been 12,300 shares per day over the past 30 days. Misonix has a market cap of $85.6 million and is part of the health care sector and health services industry. Shares are down 10.67% year-to-date as of the close of trading on Friday.

Misonix, Inc., a surgical device company, designs, manufactures, and markets therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical applications worldwide. The company has a P/E ratio of 16.7. Currently, there are no analysts who rate Misonix a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MSON - FREE

TheStreet Quant Ratings

rates Misonix as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, robust revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Misonix Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

First Commonwealth Financial (FCF) - FREE Research Report

Claus Gary R, who is Director at First Commonwealth Financial, bought 2,500 shares at $8.68 on Sept. 8, 2015. Following this transaction, the Director owned 27,579 shares meaning that the stake was boosted by 9.97% with the 2,500-share transaction.

The shares most recently traded at $8.93, up $0.25, or 2.82% since the insider transaction. Historical insider transactions for First Commonwealth Financial go as follows:

  • 4-Week # shares bought: 1,000
  • 12-Week # shares bought: 1,000
  • 24-Week # shares bought: 1,000

The average volume for First Commonwealth Financial has been 359,900 shares per day over the past 30 days. First Commonwealth Financial has a market cap of $769.5 million and is part of the financial sector and banking industry. Shares are down 4.01% year-to-date as of the close of trading on Tuesday.

First Commonwealth Financial Corporation, a financial holding company, provides various consumer and commercial banking services to individuals, and small and mid-sized businesses in the United States. The stock currently has a dividend yield of 3.24%. The company has a P/E ratio of 16.3. Currently, there are no analysts who rate First Commonwealth Financial a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FCF - FREE

TheStreet Quant Ratings

rates First Commonwealth Financial as a

buy

. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, expanding profit margins and reasonable valuation levels. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

First Commonwealth Financial Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.